Armistice Capital’s Genelux GNLX Stock Holding History

Armistice Capital’s Portfolio GNLX Stock Details GNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-900,000	Closed	-$1.75M	–	286
2024 Q2	$1.75M	Buy	+900,000	New	+$3.06M	0.02%	151

Other funds holding GNLX

WDC

Woodward Diversified Capital Bakersfield, California $220M AUM 30.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PWM

Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Armistice Capital's GNLX Position: Q3 2024 in Review

Armistice Capital sold out of Genelux (GNLX) in Q3 2024, closing a stake of 900,000 shares — an estimated $1.75M sold.

Armistice Capital first reported a position in GNLX in Q2 2024 and held it in 1 quarter. The position peaked at $1.75M in Q2 2024. 57 funds tracked by Wall St. Rank hold GNLX as of Q3 2024.

Armistice Capital reported no remaining Genelux position as of Q3 2024 after selling out during the quarter.
Armistice Capital sold 900,000 Genelux shares in Q3 2024, an estimated $1.75M.
Armistice Capital first reported a position in Genelux in Q2 2024 and held it in 1 quarter.
Armistice Capital's Genelux position peaked at $1.75M in Q2 2024.
57 funds tracked by Wall St. Rank held Genelux as of Q3 2024.

Based on Armistice Capital's 13F filing for Q3 2024, filed 14 Nov 2024.